Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Teva | Tel Aviv | Healthcare | Pharmaceuticals | ILS 89.24B | -25.2x | -0.43 | ILA 7,870 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
OPKO Health Inc | Tel Aviv | Healthcare | Healthcare Providers & Services | ILS 3.65B | -7.9x | -0.25 | ILA 549.20 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mediterranean Towers | Tel Aviv | Healthcare | Healthcare Providers & Services | ILS 1.61B | 8.4x | 0.25 | ILA 1,071 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kamada | Tel Aviv | Healthcare | Pharmaceuticals | ILS 1.54B | 26.2x | 0.19 | ILA 2,679 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ilex Medical | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 838.83M | 15x | -0.91 | ILA 7,473 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Brainsway | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 663.12M | 109.4x | 1.03 | ILA 1,771 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Compugen | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 521.40M | 89.8x | 0.85 | ILA 589.70 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sofwave Medical | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 507.11M | -40x | -0.53 | ILA 1,463 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lineage Cell Therapeutics | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 429.63M | -4.9x | -0.35 | ILA 212.50 | 4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Golden House | Tel Aviv | Healthcare | Healthcare Providers & Services | ILS 354.71M | 2.5x | 0.01 | ILA 2,258 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Batm | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 352.86M | -220.7x | 1.49 | ILA 82.90 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oramed Pharma | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 351.66M | 21.8x | 0.17 | ILA 870 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Intercure | Tel Aviv | Healthcare | Healthcare Providers & Services | ILS 275.74M | -4.2x | 0.01 | ILA 605.80 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Epitomee Medical | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 270.22M | 29.7x | 0.22 | ILA 959.70 | 5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pulsenmore | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 207.06M | -4.9x | 0.2 | ILA 409.30 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bonus Biogroup | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 181.03M | -6.5x | ILA 15.20 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Rekah | Tel Aviv | Healthcare | Pharmaceuticals | ILS 157.52M | 20.3x | 0.12 | ILA 1,372 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nissan | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 114.45M | 6.2x | 0.02 | ILA 1,265 | 2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DNA Group TR | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 109.12M | 7.3x | 0.02 | ILA 87.90 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Enlivex | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 95.11M | -1.2x | -0.04 | ILA 435 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pluri Inc | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 91.77M | -1.1x | -0.04 | ILA 1,643 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kadimastem Ltd | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 64.83M | -35.3x | -0.06 | ILA 1,468 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Matricelf | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 59.77M | ILA 374.40 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Together Startup | Tel Aviv | Healthcare | Healthcare Providers & Services | ILS 59.37M | -16.7x | -0.26 | ILA 433.20 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XTL Bio | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 59.05M | -9.1x | -0.32 | ILA 6.70 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioLine RX | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 58.79M | -0.8x | -0.02 | ILA 4.90 | 4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Endymed | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 42.94M | -6.4x | 0.02 | ILA 312 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Can Fite Biopharma | Tel Aviv | Healthcare | Pharmaceuticals | ILS 40.88M | -1.1x | -0.03 | ILA 2 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Evogene | Tel Aviv | Healthcare | Biotechnology & Medical Research | ILS 40.23M | -0.4x | -0.13 | ILA 600.40 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio View | Tel Aviv | Healthcare | Healthcare Equipment & Supplies | ILS 38.10M | 42.9x | -1 | ILA 29.30 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |